Dana dhuwit perusahaan: repligen.com (RGEN)

Lambang korporat lan logo Repligen (RGEN)

Repligen Corporation (RGEN) supplies protein purification technologies to pharma behemoths, utilizing a profitable consumables sales model. Current production efficiency has reached a plateau, necessitating strict control over R&D expenditures. The cash level indicator reflects the dynamics of cash reserves, and the current value of 0.87 captures the liquidity balance. Elite bioengineers, attracted by generous stock options and a robust scientific foundation, sustain the business stability.

RGEN - Volume dana dhuwit perusahaan Repligen Inc. ing rentang 04.07.2022 - 21.11.2026

Rincian analitis lan laporan data perusahaan Repligen Corp (RGEN)

- nilai saham lan prakiraan konsensus rega:
- indikator kapitalisasi bursa perusahaan:
Analisis kabeh metrik perusahaan:RGEN Repligen
Produk merek Repligen

For Repligen Corporation (RGEN), which is expanding its influence in bioprocessing through the acquisition of niche players, maintaining liquidity is critical for executing its M&A strategy without incurring external debt. The trend in current cash balances demonstrates the business's degree of financial autonomy, allowing investors to assess the balance between accumulating reserves and investing in growth to prevent the stagnation of the company's competitive advantages.

Karo sapa Repligen Corporation saingan

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|ionispharma.com - Dhuwit awis perusahaan|RNA: Dhuwit awis lan setara dhuwit awis perusahaan|CRSP: Dhuwit awis perusahaan|GeneDx Corp (WGS) - Dhuwit awis perusahaan|RARE: Volume dana dhuwit perusahaan|BEAM - Aset likuid perusahaan|SRPT (Sarepta Therapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Twist Bioscience Inc (TWST)|Volume dana dhuwit perusahaan TXG|Aset likuid perusahaan Intellia|Stoke - Dhuwit awis perusahaan|BLFS: Dhuwit awis lan setara dhuwit awis perusahaan|Wave Life Sciences Corp - Volume dana dhuwit perusahaan|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis perusahaan|Sionna Therapeutics Inc (SION) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Prime Medicine Corp|Dana dhuwit perusahaan tayshagtx.com|QURE - Posisi dhuwit perusahaan|Dhuwit awis perusahaan MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Posisi dhuwit perusahaan|Volume dana dhuwit perusahaan SLDB (Solid Biosciences Inc.)|Sisa dhuwit perusahaan OCGN|PacBio Corp - Volume dana dhuwit perusahaan|Benitec Biopharma Inc. (BNTC) - Dhuwit awis perusahaan|DSGN: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan RCKT|Dhuwit awis perusahaan FDMT|Dhuwit awis lan setara dhuwit awis perusahaan LXEO (Lexeo Therapeutics)|Volume dana dhuwit perusahaan KRRO|Editas Medicine, Inc. - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Silence Therapeutics Inc. SLN|Volume dana dhuwit perusahaan ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis perusahaan|Posisi dhuwit perusahaan Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis perusahaan|MGX - Aset likuid perusahaan|DTIL (Precision BioSciences Inc.) - Volume dana dhuwit perusahaan|generationbio.com (GBIO) - Aset likuid perusahaan|Dana dhuwit perusahaan Boundless Bio Inc (BOLD)|Volume dana dhuwit perusahaan Exicure Inc. (XCUR)|Dana dhuwit perusahaan imunon.com IMNN|Volume dana dhuwit perusahaan Phio Pharmaceuticals PHIO|Mustang Bio Inc - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan transcodetherapeutics.com|BNGO: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan APDN|BLUE (bluebirdbio.com) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan ImmunoPrecise Antibodies IPA|Dhuwit awis perusahaan OMGA (omegatherapeutics.com)|Volume dana dhuwit perusahaan Singular Genomics Systems, Inc. (OMIC)|Volume dana dhuwit perusahaan RGLS (Regulus Therapeutics, Inc.)|Volume dana dhuwit perusahaan Syros SYRS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan